💊Will INS018_055 be FDA-approved by 2030?
2
23
Ṁ43Ṁ70
2030
44%
chance
1D
1W
1M
ALL
Insilico Medicine's AI-designed drug for idiopathic pulmonary fibrosis, INS018_055, has entered Phase II clinical trials. Will it become (one of) the first AI-designed drugs to get FDA approval?
Get Ṁ200 play money
Related questions
Will a vaccine for HIV be approved by the FDA by 2030?
66% chance
Will aducanumab be withdrawn by the FDA by 2025?
46% chance
Will an AI-designed drug get FDA approval by the end of 2025?
33% chance
Will FDA approve an “AI doctor” for primary care before 2030?
39% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
63% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
68% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
28% chance
Will a gene therapy that edits multiple genes using CRISPR be approved by the FDA before 2030?
76% chance
Will Epi-On CXL receive FDA approval by 2025
44% chance